Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Restructuring Costs (2024 - 2025)

Bolt Biotherapeutics' Restructuring Costs history spans 1 years, with the latest figure at -$222000.0 for Q4 2024.

  • For Q4 2024, Restructuring Costs changed N/A year-over-year to -$222000.0; the TTM value through Sep 2025 reached -$222000.0, changed N/A, while the annual FY2024 figure was $3.3 million, N/A changed from the prior year.
  • Restructuring Costs for Q4 2024 was -$222000.0 at Bolt Biotherapeutics, down from $3.6 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $3.6 million in Q2 2024 and bottomed at -$222000.0 in Q4 2024.